Literature DB >> 3119360

Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia.

C DiGiovanni1, T V Riley, G F Hoyne, R Yeo, P Cooksey.   

Abstract

During a 3-year period Branhamella catarrhalis was isolated in significant numbers from 239 (1.3%) of 19,488 specimens of sputum sent for routine microbiological examination at a 700-bed general hospital. The majority of patients (83%) were over 60 years of age and 65% were male. There was a distinct seasonal variation in isolations with a peak incidence during the winter and early spring, a pattern not found with other pathogens. Susceptibility to amoxycillin decreased by approximately 50% over the 3 years, corresponding to an increased incidence of beta-lactamase-producing strains. There were minimal changes in susceptibility to other antimicrobial agents. Underlying pulmonary disease was the major factor predisposing to B. catarrhalis infection, and 71% of patients were smokers or ex-smokers.

Entities:  

Mesh:

Year:  1987        PMID: 3119360      PMCID: PMC2249296          DOI: 10.1017/s0950268800067947

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  15 in total

1.  The recognition and estimation of cyclic trends.

Authors:  J H EDWARDS
Journal:  Ann Hum Genet       Date:  1961-05       Impact factor: 1.670

2.  A selective medium for non-pathogenic aerobic Gram negative cocci from the respiratory tract: with particular reference to Branhamella catarrhalis.

Authors:  J E Corkill; T Makin
Journal:  Med Lab Sci       Date:  1982-01

3.  Branhamella catarrhalis in respiratory secretions: clinical correlation in 16 cases.

Authors:  A von Graevenitz; R R Rathbone
Journal:  South Med J       Date:  1981-09       Impact factor: 0.954

4.  Quantitative sputum culture as a means of excluding false positive reports in the routine microbiology laboratory.

Authors:  M J Wilson; D E Martin
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

5.  Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors:  G Ninane; J Joly; M Kraytman
Journal:  Br Med J       Date:  1978-02-04

6.  Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections.

Authors:  N J Slevin; J Aitken; P E Thornley
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

7.  Bronchopulmonary infection due to Branhamella catarrhalis.

Authors:  D T McLeod; F Ahmad; J T Power; M A Calder; A Seaton
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12

8.  Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.

Authors:  G V Doern; K G Siebers; L M Hallick; S A Morse
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

Review 9.  High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis.

Authors:  L Schalén; P Christensen; C Kamme; H Miörner; K I Pettersson; C Schalén
Journal:  Scand J Infect Dis       Date:  1980

10.  Branhamella (Neisseria) catarrhalis: criteria for laboratory identification.

Authors:  G V Doern; S A Morse
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

View more
  11 in total

1.  Pharyngeal carriage of Moraxella (Branhamella) catarrhalis in healthy adults.

Authors:  T Ejlertsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

Review 2.  Antibiotics for acute laryngitis in adults.

Authors:  Ludovic Reveiz; Andrés Felipe Cardona
Journal:  Cochrane Database Syst Rev       Date:  2015-05-23

3.  Branhamella catarrhalis in lower respiratory tract secretions in adults.

Authors:  H Schønheyder; T Ejlertsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

Review 4.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  Clinical features fail to distinguish respiratory infections caused by Branhamella catarrhalis from those caused by Haemophilus influenzae.

Authors:  K R Forward
Journal:  Can J Infect Dis       Date:  1992-01

6.  Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization.

Authors:  D Chen; J C McMichael; K R VanDerMeid; D Hahn; T Mininni; J Cowell; J Eldridge
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 7.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

8.  The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.

Authors:  D Chen; V Barniak; K R VanDerMeid; J C McMichael
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

Review 9.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

10.  Profiling bacterial community in upper respiratory tracts.

Authors:  Hana Yi; Dongeun Yong; Kyungwon Lee; Yong-Joon Cho; Jongsik Chun
Journal:  BMC Infect Dis       Date:  2014-11-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.